Framework agreement for analgesics, antipyretics and antidepressants
Original notice title
Portugal – Pharmaceutical products – 2026/44 - Acordo-quadro de medicamentos analgésicos, antipiréticos e antidepressivos
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Serviços Partilhados do Ministério da Saúde, EPE
- Country
- Portugal
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Dec 18, 2026
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Award Criteria
Lot 1
Buyer
Location
Lisboa, PRT
Website
Buyer profile
Identifier
509540716
Activity
Health
Lots (1)
LOT-0000
2026/44 - Acordo-quadro de medicamentos analgésicos, antipiréticos e antidepressivos
2026/44 - Acordo-quadro de medicamentos analgésicos, antipiréticos e antidepressivos
EUR 0
Estimated value
Location
Duration
Category
Award Criteria
Award details
Preço
Framework maximum value
Procurement Details
- Publication date
- 19 Nov 2026
- Languages
- Portuguese
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 807540-2026
Documents (2)
Similar tenders
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Aflibercept, ausgenommen 114,3 mg/ml (ATC-Code: S01LA05).
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Poland – Pharmaceutical products – DOSTAWA LEKÓW – 98 CZĘŚCI
Poland – Pharmaceutical products – ZP/CZD/140/26 Dostawa produktów leczniczych – 4 pakiety.
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (ATC-Code: B03XA01).
Lithuania – Pharmaceutical products – Medikamentai
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications